Capital Wealth Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
5,249
+316
+6% +$73.6K 0.01% 125
2025
Q4
$1.02M Sell
4,933
-195
-4% -$38.6K 0.01% 127
2025
Q3
$951K Sell
5,128
-498
-9% -$85.3K 0.01% 126
2025
Q2
$859K Buy
5,626
+580
+11% +$89.2K 0.01% 112
2025
Q1
$837K Sell
5,046
-1,419
-22% -$222K 0.01% 102
2024
Q4
$935K Sell
6,465
-5,461
-46% -$846K 0.01% 94
2024
Q3
$1.93M Sell
11,926
-1,013
-8% -$161K 0.02% 78
2024
Q2
$1.89M Sell
12,939
-9,256
-42% -$1.38M 0.02% 76
2024
Q1
$3.51M Sell
22,195
-1,540,088
-99% -$245M 0.04% 45
2023
Q4
$245M Buy
1,562,283
+22,557
+1% +$3.46M 2.8% 17
2023
Q3
$240M Sell
1,539,726
-1,031,409
-40% -$170M 2.95% 17
2023
Q2
$426M Buy
2,571,135
+171,991
+7% +$27.8M 5.25% 7
2023
Q1
$375M Buy
2,399,144
+317,436
+15% +$51.3M 5.07% 5
2022
Q4
$368M Buy
2,081,708
+243,096
+13% +$42M 5.38% 8
2022
Q3
$300M Buy
1,838,612
+197,556
+12% +$33.4M 5.48% 3
2022
Q2
$291M Buy
1,641,056
+724,481
+79% +$129M 5.7% 3
2022
Q1
$162M Buy
916,575
+112,890
+14% +$19.2M 3.28% 16
2021
Q4
$137M Sell
803,685
-356,962
-31% -$58.4M 3.05% 19
2021
Q3
$187M Buy
1,160,647
+85,711
+8% +$14.6M 5.15% 8
2021
Q2
$178M Buy
1,074,936
+127,946
+14% +$21.2M 5% 9
2021
Q1
$156M Buy
946,990
+486,708
+106% +$78.8M 5.08% 7
2020
Q4
$75M Buy
460,282
+90,127
+24% +$13.3M 2.89% 16
2020
Q3
$55.1M Buy
370,155
+35,094
+10% +$5.19M 2.73% 21
2020
Q2
$47.1M Sell
335,061
-137,676
-29% -$20.1M 2.69% 20
2020
Q1
$62M Buy
472,737
+148,793
+46% +$21.1M 3.9% 11
2019
Q4
$47.3M Buy
323,944
+18,296
+6% +$2.48M 2.79% 18
2019
Q3
$39M Buy
305,648
+50,727
+20% +$6.68M 2.47% 23
2019
Q2
$35.5M Buy
254,921
+239,537
+1,557% +$33.2M 2.57% 18
2019
Q1
$2.15M Sell
15,384
-9,100
-37% -$1.22M 1.41% 19
2018
Q4
$3.16M Buy
+24,484
New +$3.42M 2.1% 14
2018
Q3
Sell
-9,819
Closed -$1.19M 105
2018
Q2
$1.19M Sell
9,819
-8,790
-47% -$1.1M 0.83% 29
2018
Q1
$2.38M Buy
+18,609
New +$2.52M 1.66% 13
2017
Q4
Sell
-6,245
Closed -$812K 135
2017
Q3
$812K Buy
6,245
+3,313
+113% +$439K 0.64% 32
2017
Q2
$388K Buy
2,932
+532
+22% +$67.9K 0.06% 73
2017
Q1
$299K Hold
2,400
0.25% 51
2016
Q4
$277K Hold
2,400
0.24% 54
2016
Q3
$284K Sell
2,400
-5,490
-70% -$666K 0.22% 54
2016
Q2
$957K Buy
7,890
+5,490
+229% +$624K 0.72% 29
2016
Q1
$260K Hold
2,400
0.19% 61
2015
Q4
$247K Hold
2,400
0.23% 71
2015
Q3
$224K Hold
2,400
0.18% 77
2015
Q2
$234K Sell
2,400
-4,080
-63% -$409K 0.14% 95
2015
Q1
$651K Hold
6,480
0.34% 60
2014
Q4
$678K Sell
6,480
-5,509
-46% -$581K 0.32% 64
2014
Q3
$1.28M Hold
11,989
0.52% 40
2014
Q2
$1.25M Buy
11,989
+4,000
+50% +$404K 0.46% 41
2014
Q1
$785K Buy
+7,989
New +$741K 0.34% 52
2013
Q4
Sell
-5,400
Closed -$468K 98
2013
Q3
$468K Buy
+5,400
New +$484K 0.21% 78

Other funds holding JNJ

Capital Wealth Planning's JNJ Position: Q1 2026 in Review

Capital Wealth Planning increased its Johnson & Johnson (JNJ) stake by 6.4% in Q1 2026, buying an estimated $73.6K and bringing the position to 5,249 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #125.

Capital Wealth Planning first reported a position in JNJ in Q3 2013 and has held it in 48 quarters since. The position peaked at $426M in Q2 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Wealth Planning held 5,249 shares of Johnson & Johnson worth $1.28M as of Q1 2026.
  • Capital Wealth Planning bought 316 Johnson & Johnson shares in Q1 2026, an estimated $73.6K.
  • Johnson & Johnson made up 0.01% of Capital Wealth Planning's portfolio in Q1 2026, its #125 holding.
  • Capital Wealth Planning first reported a position in Johnson & Johnson in Q3 2013 and has held it in 48 quarters since.
  • Capital Wealth Planning's Johnson & Johnson position peaked at $426M in Q2 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Wealth Planning's 13F filing for Q1 2026, filed 15 May 2026.